Single-center, real-world experience with granulocyte colony-stimulating factor for management of leukopenia following kidney transplantation.

Stephanie HamelVicky KuoDeirdre SawinskiDavid JohnsonRoy D BloomMelissa BleicherSimin GoralMary Ann LimJennifer Trofe-Clark

Published in: Clinical transplantation (2019)

In kidney recipients with leukopenia, G-CSF may be helpful to achieve WBC count recovery in addition to changes in immunosuppression and prophylaxis medications. Prospective, randomized data are still needed to determine optimal G-CSF dosing in this population.

Keyphrases

kidney transplantation
peripheral blood
double blind
open label
placebo controlled
electronic health record
phase iii
big data
phase ii
machine learning
data analysis